Eton Pharmaceuticals (ETON) PT Lowered to $11 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts ETON Hot Sheet
Price: $63.05 -2.14%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 18
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 18
Join SI Premium – FREE
H.C. Wainwright analyst Raghuram Selvaraju lowered the price target on Eton Pharmaceuticals (NASDAQ: ETON) to $11.00 (from $14.00) while maintaining a Buy rating.
You May Also Be Interested In
- Morgan Stanley Double Downgrades Gujarat Energy (GUJENERG:IN) to Underweight
- Asymchem Laboratories Tianjin Co Ltd (002821:CH) PT Raised to RMB156 at Morgan Stanley
- Unigroup Guoxin Microelectronics (002049:CH) PT Lowered to RMB52 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
